AMERICAN ALLIANCE FOR BIOMANUFACTURING

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	4	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
CASSIDY & ASSOCIATES, INC.	—	4

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	3
SENATE	2

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Science/Technology	Science/Technology	4
Manufacturing	Manufacturing	4

Bills Explicitly Cited (12)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 2756119th Congress

National Biotechnology Initiative Act of 2025

2026 · third_quarter · Firm: CASSIDY & ASSOCIATES, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $60,000

Matched citations: H.R.2756

H.R. 2756119th Congress

National Biotechnology Initiative Act of 2025

2026 · third_quarter · Firm: CASSIDY & ASSOCIATES, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $60,000

Matched citations: H.R.2756

S. 1387119th Congress

National Biotechnology Initiative Act of 2025

2026 · third_quarter · Firm: CASSIDY & ASSOCIATES, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $60,000

Matched citations: S.1387

S. 1387119th Congress

National Biotechnology Initiative Act of 2025

2026 · third_quarter · Firm: CASSIDY & ASSOCIATES, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $60,000

Matched citations: S.1387

Show 8 more cited filings

S. 4781119th Congress

Make More in America Act of 2026

2026 · third_quarter · Firm: CASSIDY & ASSOCIATES, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $60,000

Matched citations: S.4781

S. 4781119th Congress

Make More in America Act of 2026

2026 · third_quarter · Firm: CASSIDY & ASSOCIATES, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $60,000

Matched citations: S.4781

H.R. 2756119th Congress

National Biotechnology Initiative Act of 2025

2026 · second_quarter · Firm: CASSIDY & ASSOCIATES, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $60,000

Matched citations: H.R.2756

H.R. 2756119th Congress

National Biotechnology Initiative Act of 2025

2026 · second_quarter · Firm: CASSIDY & ASSOCIATES, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $60,000

Matched citations: H.R.2756

S. 1387119th Congress

National Biotechnology Initiative Act of 2025

2026 · second_quarter · Firm: CASSIDY & ASSOCIATES, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $60,000

Matched citations: S.1387

S. 1387119th Congress

National Biotechnology Initiative Act of 2025

2026 · second_quarter · Firm: CASSIDY & ASSOCIATES, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $60,000

Matched citations: S.1387

S. 4781119th Congress

Make More in America Act of 2026

2026 · second_quarter · Firm: CASSIDY & ASSOCIATES, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $60,000

Matched citations: S.4781

S. 4781119th Congress

Make More in America Act of 2026

2026 · second_quarter · Firm: CASSIDY & ASSOCIATES, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $60,000

Matched citations: S.4781

Source: Senate LDA

AMERICAN ALLIANCE FOR BIOMANUFACTURING — Lobbying Disclosure | Poliscope